The AnteoTech (ASX:ADO) share price closed 43% higher today

The AnteoTech share price boomed over 40% higher today. Let's check out the company's latest announcement to see what's up.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Anteotech Ltd (ASX: ADO) share price gained a whopping 43.18% today, closing the day trading at 32 cents.

AnteoTech is a surface chemistry company with intellectual property in its core technology product groups. These include AnteoCoat, AnteoBind and AnteoRelease. The company's customers operate in the life sciences, diagnostics, energy and medical devices markets.

With no recent company announcements, let's take a look at what could be driving the AnteoTech share price.

AnteoTech share price zooms after Ellume secures US contract

Earlier this month, AnteoTech announced that its client, Ellume, had signed a deal with the US Defence Department for emergency use authorisation of its COVID-19 at-home test.

Ellume integrates AnteoBind technology in its proprietary quantum dot diagnostics platform.

The Ellume COVID-19 home test, incorporating AnteoBind, is the first non-prescription over-the-counter self-test authorised by the US Food and Drug Administration (FDA) for emergency use.

AnteoBind is a key element of AnteoTech's own COVID-19 Antigen Rapid Test currently in development and several other assays marketed globally.

AnteoTech advised that it has worked closely with Ellume over recent months to ensure it could supply the required volumes of AnteoBind.

The company expects that Ellume's requirement for AnteoBind will increase modestly over coming months as supply to the US markets takes off.

Words from the CEO

Commenting on the Ellume agreement, AnteoTech CEO Derek Thomson said:

We are delighted to be involved with Ellume's success and we congratulate the company on their announcement.

Ellume was the original seed customer in AnteoTech's strategy to demonstrate the value that AnteoBind can bring to assay development and it is pleasing to see that strategy now delivering market recogition.

I commend the work of AnteoTech's Life Science team under the leadership of Charlie Huang for their continued work to make AnteoBind a key element in the development of diagnostic products in global markets.

The AnteoTech share price has exploded more than 648% higher over the previous 12-month period.

Motley Fool contributor Gretchen Kennedy has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ASX Share Market News

Sell buy and hold on a digital screen with a man pointing at the sell square.
Broker Notes

Donw 54% in a year are Xero shares now a buy, hold or sell?

A leading analyst provides his outlook for Xero’s beaten down shares.

Read more »

A man looking at his laptop and thinking.
Broker Notes

2 top ASX 200 shares tipped to return 23% to 45%

Morgans thinks these shares could rocket from current levels.

Read more »

Young couple having pizza on lunch break at workplace.
Growth Shares

3 ASX growth shares experts think could double

Three beaten-up names, three very bullish targets.

Read more »

A smiling boy holds a toy plane aloft while a girl watches on from a car near an airport runway.
Broker Notes

3 ASX 200 shares tipped to return 27% to 87%

These stocks could really take off.

Read more »

Investor sitting in front of multiple screens watching share prices
ASX Share Market News

5 things to watch on the ASX 200 on Wednesday

It looks set to be a better day for Aussie investors.

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
ASX Share Market News

$10,000 invested in BHP and CBA shares three years ago is now worth…

Here’s how the returns from BHP and CBA shares stack up over the past three years.

Read more »

An unhappy man in a suit sits at his desk with his arms crossed staring at his laptop screen as the PointsBet share price falls
ASX Share Market News

Buy, hold sell: Telstra, Origin Energy & Westpac shares

One of these ASX shares is likely to fall from here, according to experts.

Read more »

Two young risk-taking men pose for the camera as they jump off a cliff into the sea.
ASX Share Market News

2 ASX shares tipped by brokers to return 25% and 42%

There is plenty of potential for growth ahead.

Read more »